We are live on
!
Find out more
Nuveen Portfolio holdings
AUM
$419B
1-Year Est. Return
43.02%
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$382B
AUM Growth
+$3.03B
(+0.8%)
Cap. Flow
-$4.9B
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
34.7%
Holding
3,317
New
65
Increased
1,141
Reduced
1,398
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$2.55B |
| 2 |
NHYB
Nuveen High Yield Corporate Bond ETF
NHYB
|
+$1.61B |
| 3 |
Apple
AAPL
|
+$732M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$567M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.96B |
| 2 |
NVIDIA
NVDA
|
+$842M |
| 3 |
Amazon
AMZN
|
+$783M |
| 4 |
Microsoft
MSFT
|
+$646M |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$602M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33% |
| 2 | Financials | 12.48% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Enliven Therapeutics
ELVN
$3.28B
| $1.62M | ﹤0.01% |
105,448
-2,796
| -3% | -$55.7K |
|
2352
Sturm, Ruger & Co
RGR
$684M
| $1.62M | ﹤0.01% |
49,639
-3,218
| -6% | -$119K |
|
2353
Rush Enterprises Class B
RUSHB
$6.44B
| $1.62M | ﹤0.01% |
43,153
+444
| +1% | +$16.2K |
|
2354
OmniAb
OABI
$670M
| $1.62M | ﹤0.01% |
874,512
+2
| +0% | +$3 |
|
2355
Inter&Co
INTR
$2.26B
| $1.61M | ﹤0.01% |
190,150
| – | – |
|
2356
Beazer Homes USA
BZH
$890M
| $1.61M | ﹤0.01% |
79,374
+1,351
| +2% | +$30.1K |
|
2357
Columbus McKinnon
CMCO
$486M
| $1.61M | ﹤0.01% |
93,189
-229,590
| -71% | -$3.68M |
|
2358
NET Power
NPWR
$144M
| $1.6M | ﹤0.01% |
702,391
| – | – |
|
2359
First Mid Bancshares
FMBH
$1.32B
| $1.6M | ﹤0.01% |
40,946
-2,849
| -7% | -$108K |
|
2360
MiMedx Group
MDXG
$682M
| $1.59M | ﹤0.01% |
235,492
-14,293
| -6% | -$100K |
|
2361
American Battery Technology Co
ABAT
$322M
| $1.59M | ﹤0.01% |
477,096
+336,191
| +239% | +$1.57M |
|
2362
Teekay
TK
$1.2B
| $1.59M | ﹤0.01% |
176,357
-254,824
| -59% | -$2.34M |
|
2363
Merchants Bancorp
MBIN
$2.39B
| $1.59M | ﹤0.01% |
46,718
-1,653
| -3% | -$54.3K |
|
2364
SandRidge Energy
SD
$514M
| $1.59M | ﹤0.01% |
110,138
-120,470
| -52% | -$1.59M |
|
2365
BrightView Holdings
BV
$964M
| $1.59M | ﹤0.01% |
125,276
| – | – |
|
2366
Pacific Biosciences
PACB
$504M
| $1.59M | ﹤0.01% |
848,219
+578,035
| +214% | +$1.11M |
|
2367
Erasca
ERAS
$4.98B
| $1.58M | ﹤0.01% |
424,713
-25,343
| -6% | -$71.3K |
|
2368
NETGEAR
NTGR
$600M
| $1.58M | ﹤0.01% |
64,407
-25,859
| -29% | -$744K |
|
2369
Amerant Bancorp
AMTB
$1.16B
| $1.58M | ﹤0.01% |
80,885
+7,768
| +11% | +$145K |
|
2370
BlackBerry
BB
$4.82B
| $1.58M | ﹤0.01% |
417,110
| – | – |
|
2371
Embecta
EMBC
$334M
| $1.57M | ﹤0.01% |
132,549
-64,688
| -33% | -$853K |
|
2372
Adtran
ADTN
$581M
| $1.57M | ﹤0.01% |
180,632
-4,669
| -3% | -$40.5K |
|
2373
Kura Oncology
KURA
$957M
| $1.57M | ﹤0.01% |
151,070
-248,719
| -62% | -$2.61M |
|
2374
AMN Healthcare
AMN
$1.34B
| $1.57M | ﹤0.01% |
99,355
-10,596
| -10% | -$189K |
|
2375
Allient
ALNT
$1.97B
| $1.56M | ﹤0.01% |
29,060
| – | – |
|
Similar funds
Nuveen's Q4 2025 Portfolio in Review
As of Q4 2025, Nuveen held 3,317 positions worth $382B, up 0.8% from $379B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4%. Nuveen opened 65 new positions and exited 67, leaving the 3,317-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q4 2025 buy was TotalEnergies: 5,227,521 shares worth $341M.
- Nuveen added most to Nuveen International Aggregate Bond ETF in Q4 2025, an estimated $2.55B increase.
- Nuveen's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $1.96B.
- Nuveen fully exited Janus Henderson AAA CLO ETF in Q4 2025, selling an estimated $602M.
- Nuveen's ten largest holdings make up 35% of its $382B portfolio in Q4 2025.
- Nuveen opened 65 new positions and closed 67 in Q4 2025.
- Nuveen's portfolio value rose 0.8% quarter-over-quarter to $382B.
Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.